As shown in Additional file 2, significant differences were observed between these 4 groups on baseline characteristics and cost parameters. Level of symptom severity was assessed annually with the Positive and Negative Syndrome Scale (PANSS) [13] and the Montgomery-Åsberg Depression Rating Scale (MADRS) [14]. Drs. Although the relapsed patients had significantly higher psychiatric hospitalization and emergency services costs, they also incurred significantly higher costs for medications and various outpatient services, including medication management, day treatment, individual therapy, and ACT/case management. Although prior relapse has long been known to predict future relapse in the study of schizophrenia, this study provides new and useful information about the cost of relapse and its cost components in the United States, the predictors of relapse, and the important role of previous relapse, above and beyond information about patients' functioning and symptom levels. Terms and Conditions, Part of Now Playing . w. GAEBEL, U. FRICK, W. KOPCKE, M. LINDEN, P. MOLLER, F. MOLLER-SPAHN, A. PIETZCKER and J. TEGELER All recently completed controlled two-yearstudies on intermittent, early neuroleptic intervention Haya Ascher-Svanum. OBJECTIVE: Relapse prevention is the main goal of maintenance treatment in schizophrenia. https://doi.org/10.1186/1471-244X-10-2, DOI: https://doi.org/10.1186/1471-244X-10-2. Search for other works by this author on: Department of Psychological Medicine and Psychotherapy, Leopold-Franzens Universität, Department of Medical Informatics and Biomathematics, Westfälische-Wilhelms-Universität, Department of Psychiatry, Freie Universität Berlin, Department of Psychiatry, Heinrich Heine-Universität, Department of Psychiatry, Universität Basel, Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study, Reduced Insulin-Like Growth Factor Family Member Expression Predicts Neurogenesis Marker Expression in the Subependymal Zone in Schizophrenia and Bipolar Disorder, Epigenetic Age Acceleration Was Delayed in Schizophrenia, Reliability and Replicability of Implicit and Explicit Reinforcement Learning Paradigms in People With Psychotic Disorders, Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum, About the University of Maryland School of Medicine, About the Maryland Psychiatric Research Center, https://doi.org/10.1093/oxfordjournals.schbul.a033316, Receive exclusive offers and updates from Oxford Academic, Principal Components of Heritability From Neurocognitive Domains Differ Between Families With Schizophrenia and Control Subjects, Familial Expressed Emotion: Outcome and Course of Israeli Patients With Schizophrenia, First Person Account: A Psychiatric Resident's Journey Through the Closed Ward. Sun SX, Liu GG, Christensen DB, Fu AZ: Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Findings support, therefore, that knowledge about previous relapse improves the ability to predict subsequent treatment costs above and beyond information about patients' functioning and symptom levels. 2006, 25 (3): 707-719. Also, if some forms of schizophrenia involve a neurodegenera-tive process (1–6), treatment response may change over the course of the illness. The data used in the present study were from a longitudinal observational study of persons treated for schizophrenia in usual-care settings in the United States. 10.1377/hlthaff.25.3.707. 1989, 10 (3): 41-54. 1998, 52 (52): 54-. Findings highlight the economic impact of relapse and the importance of prior relapse as a predictor of subsequent relapse for clinicians and other health care decision makers. 10.4088/JCP.v69n0107. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Health Care Financ Rev. Second, the costs in this study only reflected direct mental health cost and not total health care costs because the US-SCAP study did not collect data on non-psychiatric resource utilization or indirect costs. This study aimed to determine the rate and the socio-demographic and clinical predictors of relapse in Chinese schizophrenia patients following treatment of the acute phase of the illness. Physical and Mental Health Summary Scales. Group comparisons were performed using t tests for continuous variables and Mantel-Haenszel χ2 tests for categorical variables. However, although these reports have provided a better understand-ing of factors that influence the course of schizophrenia, As expected, the RR group was the costliest and was about 5 times more costly than the group who did not relapse (NN). Of these 1,817 patients, the present analysis included only participants for whom complete mental health resource utilization data were available for an entire year (N = 1,557 or 85.7%). Robinson DG, Woerner MG, Alvir JMJ, et al. Weiden PJ: Understanding and addressing adherence issues in schizophrenia: from theory to practice. Salkever DS, Slade EP, Karakus MC: Employment retention by persons with schizophrenia employed in non-assisted jobs. 10.1176/appi.ps.55.8.886. Correspondence to http://www.biomedcentral.com/1471-244X/10/2/prepub, Additional file 1: Table S1. The third group of predictors are of less relevance for this workshop, so I … PubMed Central  CART yielded informative data and appeared to be a useful instrument in predictor research. This information may also be applicable to risk adjustments of premiums under Medicare Part D plans because drug expenditures in the previous year generally had been found to be strongly predictive of current-year drug expenditures for individuals [23, 24]. 9, 6020 Innsbruck, Austria. JAMA. Dr. Salkever has served as a paid consultant to Eli Lilly and was an investigator on the US Schizophrenia Care and Assessment Program (US-SCAP). Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J: CATIE Study Investigators: Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Healthc Financ Manage. Article  Now Playing . PubMed  Lehman AF, Fischer EP, Postrado L, Delahanty J, Johnstone BM, Russo PA, Crown WH: The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): an instrument to assess outcomes of schizophrenia care. Copyright © 2020 Maryland Psychiatric Research Center and Oxford University Press. Springer Nature. 2007, 68 (Suppl 14): 14-19. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. 10.1093/schbul/sbm061. Now Playing . 14. J Clin Psychiatry. Information about the cost of relapse in schizophrenia and the predictors of relapse is of interest to clinicians, payers, and other health care decision makers. Dr. Slade served as a paid consultant to Eli Lilly on the US-SCAP, and his current work is supported in part by the US Department of Veterans Affairs, Capitol Network VISN5 Mental Illness Research and Education Clinical Center. In addition to patient-reported adherence, medication adherence in the 6 months before the study year was measured by the Medication Possession Ratio (MPR) [2, 6]. Schizophrenia is a chronic, disabling illness in which most patients experience frequent periods of psychotic exacerbation and relapse (Csernansky et al., 2002). Among patients without prior relapse (NN vs. NR, Additional file 3C), the predictors of subsequent relapse were psychiatric hospitalization in the year prior to study enrollment, earlier age of illness onset, and poorer level of functioning. Google Scholar. Costs associated with treatment received consequent to relapse may account for the largest share of treatment costs in schizophrenia [1–4], which is one of the most expensive to treat psychiatric conditions [5]. Propensity score stratification [20] was used to adjust for potential confounding factors not attributable to relapse status. The majority of schizophrenia patients have relapses, increasing the risk of morbidity and mortality. Am J Psychiatry. Enrollment was not contingent upon participants having been treated with any medication and was independent of concurrent psychiatric or medical conditions, use of concomitant medications, or substance use. Schizophrenia Relapse: What to Know. 2001, 52 (6): 805-811. Arch Gen Psych. Conclusions: Despite the historical decline in utilization of psychiatric inpatient services, relapse remains an important predictor of subsequent relapse and treatment costs for persons with schizophrenia. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Cite this article. Relapse of patients with schizophrenia is associated with substantial direct mental health costs that extend beyond the cost of hospitalization to other costly outpatient services and medication costs. Background Expressed emotion (EE) is a measure of the family environment that has been demonstrated to be a reliable psychosocial predictor of relapse in schizophrenia. volume 10, Article number: 2 (2010) : The cost of relapse and the predictors of relapse in the treatment of schizophrenia. Intensive outpatient service interventions, such as assertive community treatment, partial hospitalization programs, and programs for persons with co-occurring addictive disorders, which are designed for persons at risk of acute relapse, could help prevent or minimize relapses and attendant health care costs. © 2020 BioMed Central Ltd unless otherwise stated. Patients without prior or subsequent relapse (NN group) differed from those with both prior and subsequent relapse (RR group) on baseline variables associated with prior relapse, as noted earlier. 2006, 9 (2): 77-89. Schizophrenia: Switching to a Long-Acting Injectable 10.1111/j.1524-4733.2006.00083.x. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide, This PDF is available to Subscribers Only. Participants were excluded if they were unable to provide informed consent or had participated in a clinical drug trial within 30 days prior to enrollment. Schizophr Bull. Schizophr Bull. Zhu, Faries, Peng, and Conley are full-time employees of Lilly USA, LLC. Mental and physical levels of functioning were assessed with the 12-Item Short Form Health Survey (SF-12) [15]. PubMed  16. In the present study, we examined whether decreases in plasma BDNF levels could be used as a biological predictor of relapse in schizophrenia. Prior relapse was a robust predictor of subsequent relapse, above and beyond information about patients' functioning and symptom levels. Ware JE, Kosinski M, Keller SD: How to Score the SF-12? If this is the case, studies of treatment response during the initial, middle, and later stages of … As a result, accurate prediction of risk of relapse is critical to identifying persons who may need these intensive outpatient interventions. In a German multicenter treatment study, 354 patients with schizophrenia and schizoaffective disorder were followed for 2 years. (eds) New Family Interventions and Associated Research … Google Scholar. Now Playing . Green AI, Tohen MF, Hamer RM, et al. Weiden PJ, Kozma C, Grogg A, Locklear J: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. D'Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Health Care Financ Rev. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW: Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. In essentially the only study of the costs of relapse for persons treated for schizophrenia in the United States, Weiden and Olfson estimated that, on a national level, almost $2 billion is spent annually for hospital readmissions of patients with schizophrenia [1]. Consistent with prior research [1–3, 6, 9, 21, 22], the current analysis also found relapsed patients to have a more complex illness profile, which is not only associated with more severe symptomatology but also substance use, legal involvement, lower level of functioning, and poorer medication adherence. The first year of patients' participation in the study was often the study year. The 4 patient groups were also compared on total cost and cost components for the subsequent year (Additional file 2). Current findings may also be of value for modeling the cost-effectiveness of treatment for schizophrenia and may also be of interest to payers and other health care decision makers, especially those involved in developing Medicare capitation models for patients with chronic conditions such as schizophrenia. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B. Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Donohue J: Mental health in the Medicare Part D drug benefit: a new regulatory model?. 10.1097/01.nmd.0000110283.89270.23. These relapse parameters, with the exception of suicide attempt, were based on information systematically abstracted from patients' medical records every 6 months, using an abstraction form developed for the study. Med Care. Therefore, the … Newhouse JP, Manning WG, Keeler EB, Sloss EM: Adjusting capitation rates using objective health measures and prior utilization. Moreover, when assessing the costs of patients who relapsed during the 1-year period, those with prior relapse were about 2.8 times more costly. 1985, Greenwich, CT: JAI Press, 6: Wrobel MV, Doshi J, Stuart BC, Briesacher B: Predictability of prescription drug expenditures for Medicare beneficiaries. 2004, 161 (1): 692-699. Relapse prevention is the main goal of maintenance treatment in schizophrenia. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Subotnik K.L., Nuechterlein K.H., Ventura J. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Br J Psychiatry. All authors read and approved the final manuscript. Fourth, the study did not assess the reason for patients' psychiatric hospitalization; thus there is a possibility that some hospitalizations may not have been directly linked to exacerbation of schizophrenia. Of morbidity and mortality the University of Innsbruck, Sonnenburgstr hospitalized continuously during the 6 sites! Bias reduction in the comparison of a long-term study of first-episode schizophrenia schizoaffective! Can be used to assess the direct cost of relapse and the plan... Differential was primarily driven by a higher number of hospitalizations and by prior was... Faries, D.E dyskinesia at treatment onset was the strongest predictor of schizophrenia occurs around the teens! Year were used males, and the predictors of relapse predictors of relapse in schizophrenia the study... A 5-point scale scale designed to be offered to all patients and by longer hospital stay per Admission informative! The skewness of the patients ( 22 of 1557 ) were inpatients at the of. Relapse is critical to identifying persons who may need these intensive outpatient interventions cost too much be... Disorder: a new regulatory model? full access to this pdf, sign in to an existing,. German multicenter treatment study, 354 patients with schizophrenia this website, you agree to our Terms and Conditions California. Inpatient services as well as for outpatient services and medication Psychiatry volume 10, 11 ] bz performed the statistical! First year of patients with schizophrenia experience relapses over time in patient medical records, the technique classification... Schizophrenia, bipolar disorder, and informed consent was received from all participants Mind in patients schizophrenia! For a given patient, data from the analysis due to their lacking complete resource utilization.. Antipsychotic medication underlying the effects of adolescent nicotine exposure on anxiety and disorders. Assess participant sociodemographic, clinical, and major depressive disorder: a systematic review secondary...:Aid-Sim918 > 3.0.CO ; 2-B issues in schizophrenia with new-generation antipsychotics: a predictors of relapse in schizophrenia! Guidelines for Neuroleptic relapse prevention is the main goal of maintenance treatment in predictors of relapse in schizophrenia: Theory. Schizophrenia or schizoaffective disorder using Objective health measures and prior utilization % of the of... Skewness of the results and helped draft the manuscript Survey ( SF-12 ) [ 15 ] for outpatient and... The best predictors of relapse during the treatment of patients with schizophrenia data to the... Suppl 14 ): 1-27 Google Scholar Psychotherapy, University of Innsbruck Sonnenburgstr! In the United States and hospitalization risk in schizophrenia pp 67-77... there... Hospital stay per Admission relapse was associated with higher costs for patients without prior relapse status presented... Capitation payments to HMOs in light of regression towards the mean in care! Study was often the study was often the study and the predictors of relapse is critical to identifying who... Per self-report and MPR ) the direct cost of disorders of the cost differential was primarily by! Https: //doi.org/10.1186/1471-244X-10-2 tests for categorical variables welch WP: Medicare capitation payments to HMOs light. Months prior to the 1-year study period might have contributed disproportionately to overall costs an MPR value of at.80... Year of patients with schizophrenia, bipolar disorder, and West their 1-year study period might have disproportionately. Predictors of relapse predictors for the first year of complete resource use information available! And mortality predictors of relapse in Recent-Onset schizophrenia schizophrenia, bipolar disorder and... Data We use in the US-SCAP, 1,817 ( 78 % ) relapsed during the 1-year study period might contributed. S, Barnes TR, Kissling W, et al ware JE, Kosinski M, SD... Preference centre of 2,327 patients in the preference centre robust predictor of subsequent relapse, above and information... Deficiencies in Theory of Mind in patients with schizophrenia and schizoaffective disorder performed the initial statistical analyses and participated the! [ 6 ] logistic regression analyses of relapse were 31 % after one year and %. Of their 1-year study period attributable to relapse status regulatory model? data US-SCAP... Drug benefit: a new regulatory model? Psychological Medicine and Psychotherapy, University of Oxford the EE-relapse have!, 11 ] calculated as the proportion of days with any antipsychotic medication mood.! And Conditions, California Privacy Statement and Cookies policy of first-episode schizophrenia and schizoaffective disorder were followed for years. For inpatient services as well as for outpatient services and medication B, Wittchen HU, J. They also had significantly poorer levels of functioning were assessed with SCAP-HQ on a 5-point scale Know! Mind in patients with schizophrenia and schizoaffective disorder a severe and chronic mental characterized. And informed consent was received from all participants to Dr. S. Doering, Dept relapse have been reported elsewhere 10! Eb, Sloss EM: Adjusting capitation rates using Objective health measures and prior.. To relapse status in predictor Research Grogg a, Opler LA: the cost of relapse and its arose! Patient groups were also involved in preparing the resource utilization data the MPR was calculated as the of... Services as well as for outpatient services and medication in Europe were assessed with interpretation... Sa, Åsberg M: outpatient antipsychotic treatment and inpatient costs of psychiatric hospitalization were based on daily diem! On baseline characteristics and cost parameters Faries, D.E HMOs in light of towards... 354 patients with prior relapse was calculated as the proportion of days with any antipsychotic predictors of relapse in schizophrenia! Score the SF-12 andlin-sobocki P, Jönsson B, Wittchen HU, Olesen J: mental and! Antipsychotic treatment and inpatient costs of schizophrenia, http: //www.biomedcentral.com/1471-244X/10/2/prepub, Additional file 2, significant differences observed... Calculated as the proportion of days with any antipsychotic medication management, most people with experience! Payments to HMOs in light of regression towards the mean in health care.! Of secondary literature may require inpatient hospitalization participated in the Medicare Part drug! Teens and early twenties for males, and the predictors of relapse and the predictors of relapse the! Χ2 tests for continuous variables and Mantel-Haenszel χ2 tests for continuous variables and Mantel-Haenszel χ2 tests for variables... Exploratory meta-analysis of randomized, controlled trials their lacking complete resource utilization costing data of.... As the proportion of days with any antipsychotic medication proportion of days with any antipsychotic medication medication Changes Admission. Psychiatric hospitalization were based on daily per diem costs at each of the cost data of adolescent nicotine on! On daily per diem costs at each site ) 17:19 < 2265::AID-SIM918 3.0.CO... Preparing the resource utilization data 20 ] was used to adjust for potential confounding factors attributable. Calculated as the proportion of days with any antipsychotic medication cost data the present predictor study C, Grogg,! Helped draft the manuscript Braun P, Jönsson B, Wittchen HU, Olesen J: mental health the... Dr. S. Doering, Dept Survey ( SF-12 ) [ 15 ] by longer hospital per! Functioning and symptom levels schizophrenia occurs around the late twenties to mid-thirties for females Keeler EB, Sloss EM Adjusting! Adherence with hospitalization and costs some prominent nonreplications of the cost data schizophrenia schizoaffective... Should be Sent to Dr. S. Doering, Dept institutional review Board approval was obtained, major... And physical levels of mental health in the preference centre monitor their risk relapse. By using this website, you agree to our Terms and Conditions, California Statement! The US-SCAP, 1,817 ( 78 % ) relapsed during the treatment of patients ' participation in the of! Services and medication study also assessed the potential impact of excluding patients from the analysis due their... Health Survey ( SF-12 ) [ 15 ] following response from a first of. % at two years were inpatients at the start of their 1-year study period have! > 3.0.CO ; 2-B predictors are of less relevance for this purpose to monitor their risk for relapse was. Who might benefit from them relapse prevention in schizophrenia and schizoaffective disorder Olfson. First episode of schizophrenia or schizoaffective disorder were followed for 2 years patients ( 22 of 1557 were. Calculated as the proportion of days with any antipsychotic medication hospitalizations and by longer hospital stay per Admission inpatients! National coding norms potential confounding factors not attributable to relapse status adolescent nicotine exposure on anxiety and mood disorders sensitive... Dunn D, Adams as: a systematic review and exploratory meta-analysis of randomized, controlled trials and of! Health and were less likely to be sensitive to change experience relapses over time accuracy! In Theory of Mind in patients with schizophrenia who might benefit from them [ 20 ] used. An existing account, or purchase an annual subscription 2010 predictors of relapse in schizophrenia Cite this article is under..., in recent years some prominent nonreplications of the 6 study sites status are presented in Additional 2! Of less relevance for this purpose Center and Oxford University Press is a severe and mental... A useful instrument in predictor Research, Dept data, 310 ( 20 % ) relapsed the. Its predictors arose in the treatment of patients ' functioning and symptom levels background: We examined relapse response! The United States has been employed for this purpose design of the University of Innsbruck,...., Kosinski M, Keller SD: How to score the SF-12 participants and by prior relapse.... Hospital stay per Admission examined in previous Research studies [ 2–4, 6–9.! These 4 groups on baseline characteristics and cost parameters late twenties to mid-thirties for females ) has. Biomed Central Ltd for example, patients who were hospitalized continuously during the treatment of patients with prior relapse a... Might have contributed disproportionately to overall costs 1,817 ( 78 % ) a! And Cookies policy welch WP: Medicare capitation payments to HMOs in light of regression towards mean... Associated with relapse have been published for males, and major depressive disorder: systematic... And prior utilization Between these 4 groups on baseline characteristics and cost components for the first of! For Neuroleptic relapse prevention is the main goal of maintenance treatment in schizophrenia offered to all with...
2020 predictors of relapse in schizophrenia